Correlating skin toxicity and steroid treatment with outcomes of anti-PD-1 therapy for patients with metastatic melanoma

被引：0
|
作者：
Quach, Henry T. [1 ]
Johnson, Douglas B. [2 ]
Dewan, Anna K. [3 ]
机构：
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[3] Vanderbilt Univ, Med Ctr, Dept Dermatol, Nashville, TN USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
10388
引用
收藏
页码：AB39 / AB39
页数：1
相关论文
共 50 条
  • [41] Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
    Sagun Parakh
    John J Park
    Shehara Mendis
    Rajat Rai
    Wen Xu
    Serigne Lo
    Martin Drummond
    Catherine Rowe
    Annie Wong
    Grant McArthur
    Andrew Haydon
    Miles C Andrews
    Jonathan Cebon
    Alex Guminski
    Richard F Kefford
    Georgina V Long
    Alexander M Menzies
    Oliver Klein
    Matteo S Carlino
    British Journal of Cancer, 2017, 116 : 1558 - 1563
  • [42] Impact of Anti-PD-1 Treatment in Patients with Metastatic Melanoma Brain Lesions Treated with Stereotactic Radiosurgery
    Goel, A.
    Kumar, R. J.
    Linam, J. M.
    Huang, A. J.
    Abendroth, R. E.
    Lee, J. W.
    Andrews, B.
    Leong, S.
    Leng, L. Z.
    Minor, D.
    Nosrati, M.
    Vosoughi, E.
    Miller, J.
    Kashani-Sabet, M.
    Kim, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E75 - E75
  • [43] Phase I Study of Androgen Deprivation Therapy in Combination with Anti-PD-1 in Melanoma Patients Pretreated with Anti-PD-1
    Robert, Caroline
    Lebbe, Celeste
    Lesimple, Thierry
    Lundstrom, Eija
    Nicolas, Valerie
    Gavillet, Bruno
    Crompton, Philippa
    Baroudjian, Barouyr
    Routier, Emilie
    Lejeune, Ferdy J.
    CLINICAL CANCER RESEARCH, 2023, 29 (05) : 858 - 865
  • [44] Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma
    Schvartsman, Gustavo
    Ma, Junsheng
    Bassett, Roland L., Jr.
    Haydu, Lauren E.
    Amaria, Rodabe Navroze
    Hwu, Patrick
    Wong, Michael K.
    Hwu, Wen-Jen
    Diab, Adi
    Patel, Sapna Pradyuman
    Davies, Michael A.
    Hamerschlak, Nelson
    Tawbi, Hussein Abdul-Hassan
    Oliva, Isabella C. Glitza
    CANCER, 2019, 125 (23) : 4193 - 4202
  • [45] Safety and Activity of Combined Radiation Therapy (RT) and Anti-PD-1 Antibodies (PD-1) in Patients (pts) With Metastatic Melanoma
    Liniker, E.
    Kong, B.
    Menzies, A. M.
    Cooper, A. J.
    Kefford, R. F.
    Fogarty, G. B.
    Guminski, A.
    Carlino, M. S.
    Wang, T. W.
    Long, G. V.
    Hong, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E635 - E635
  • [46] Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
    Diem, S.
    Kasenda, B.
    Spain, L.
    Martin-Liberal, J.
    Marconcini, R.
    Gore, M.
    Larkin, J.
    BRITISH JOURNAL OF CANCER, 2016, 114 (03) : 256 - 261
  • [47] Response to anti-PD-1 based therapy in metastatic melanoma patients is associated with the diversity and composition of the gut microbiome
    Gopalakrishnan, Vancheswaran
    Spencer, Christine
    Reuben, Alexandre
    Prieto, Peter
    Vicente, Diego
    Karpinets, Tatiana V.
    Hudgens, Courtney W.
    Hutchinson, Diane S.
    Tetzlaff, Michael
    Lazar, Alexander
    Davies, Michael A.
    Gershenwald, Jeffrey E.
    Jenq, Robert
    Hwu, Patrick
    Sharma, Padmanee
    Allison, James
    Futreal, Andrew
    Ajami, Nadim
    Petrosino, Joseph
    Daniel-MacDougall, Carrie
    Wargo, Jennifer A.
    CANCER RESEARCH, 2017, 77
  • [48] Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
    S Diem
    B Kasenda
    L Spain
    J Martin-Liberal
    R Marconcini
    M Gore
    J Larkin
    British Journal of Cancer, 2016, 114 : 256 - 261
  • [49] Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy
    Johnson, Douglas B.
    Wallender, Erika K.
    Cohen, Daniel N.
    Likhari, Sunaina S.
    Zwerner, Jeffrey P.
    Powers, Jennifer G.
    Shinn, Lisa
    Kelley, Mark C.
    Joseph, Richard W.
    Sosman, Jeffrey A.
    CANCER IMMUNOLOGY RESEARCH, 2013, 1 (06) : 373 - 377
  • [50] Patterns of acquired resistance to anti-PD-1 antibodies in patients with metastatic melanoma (MM).
    Lee, Jenny H. J.
    Cooper, Adam James
    Lyle, Megan Kate
    Liniker, Elizabeth
    Menzies, Alexander M.
    Kefford, Richard
    Long, Georgina V.
    Carlino, Matteo S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345